Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Nov 15;15:437–445. doi: 10.2147/OAEM.S423097

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Kobayashi et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Estimated overall survival rates for patients with cholangitis-associated DIC treated by rTM preparation or AT replacement therapy.

Notes: A blue and a green line show survival curve for patients treated by rTM preparation (n = 54) and AT replacement therapy (n = 17), respectively. There was a statistically significant difference between rTM preparation and AT replacement therapy in the 60-day OS (P = 0.022).

Abbreviations: DIC, disseminated intravascular coagulation; rTM, recombinant thrombomodulin; AT, antithrombin; OS, overall survival.